# name
Are the testing needs of key European populations affected by
                hepatitis B and hepatitis C being addressed? A scoping review of
                testing studies in Europe

# metadata.dc.description.abstract[].value
AIM: To investigate whether or not key populations affected by
                hepatitis B and hepatitis C are being tested sufficiently for
                these diseases throughout the European region. METHODS: We
                searched MEDLINE and EMBASE for studies on HBV and HCV testing
                in the 53 Member States of the World Health Organization
                European Region following PRISMA criteria. RESULTS: 136
                English-language studies from 24 countries published between
                January 2007 and June 2013 were found. Most studies took place
                in 6 countries: France, Germany, Italy, the Netherlands, Turkey,
                and the United Kingdom. 37 studies (27%) addressed HBV, 46 (34%)
                HCV, and 53 (39%) both diseases. The largest categories of study
                populations were people who use drugs (18%) and health care
                patient populations (17%). Far fewer studies focused on
                migrants, prison inmates, or men who have sex with men.
                CONCLUSIONS: The overall evidence base on HBV and HCV testing
                has considerable gaps in terms of the countries and populations
                represented and validity of testing uptake data. More research
                is needed throughout Europe to guide efforts to provide testing
                to certain key populations.

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Are the testing needs of key European populations affected by
                hepatitis B and hepatitis C being addressed? A scoping review of
                testing studies in Europe